Applications

Application — Cortical surface

WIMAGINE epidural BCI exoskeleton trial, Clinatec Grenoble (NCT02550522)

Clinatec · WIMAGINE · ECoG · epidural · exoskeleton · tetraplegia

WIMAGINE epidural BCI exoskeleton trial (NCT02550522)

The ongoing Clinatec trial of the WIMAGINE wireless epidural ECoG implant for motor restoration in tetraplegia, best known for the 24-month proof-of-concept in which one participant drove a virtual avatar and a four-limb exoskeleton from decoded epidural signals. Registry facts are from ClinicalTrials.gov (verified October 28, 2026); results are from the peer-reviewed Lancet Neurology report and a follow-up stability study.

Study facts

FieldValue and source scope
RegistryNCT02550522; interventional, single-group, treatment purpose, no masking [1]
Official titleBrain Computer Interface: Neuroprosthetic Control of a Motorized Exoskeleton [1]
Sponsor and siteUniversity Hospital, Grenoble; CLINATEC, Grenoble, France [1]
StatusRecruiting [1]
DatesStarted September 2015; primary completion and study completion estimated April 2033 [1]
Enrollment5 (estimated) [1]
PopulationTraumatic tetraplegia with cervical cord injury [1]
InterventionBCI platform with two implanted, remotely powered epidural ECoG recording devices driving an exoskeleton [1]
Primary outcomeNumber of participants with adverse events, 4 years after surgery [1]
Secondary outcomesPerformance in piloting the degrees of freedom of the exoskeleton; quality-of-life evaluation (both 4 years after surgery) [1]

Published results

FieldValue and source scope
CohortTwo participants recruited into the ongoing trial; one excluded after a technical problem with the implants; the remaining participant was a 28-year-old man with C4-C5 tetraplegia [2]
ImplantTwo bilateral wireless epidural recorders, 64 electrodes each, over the upper-limb sensorimotor areas [2]
Reporting windowJune 12, 2017 to July 21, 2019; 24 months of progressive training [2]
PerformanceCortical control of a walking simulation and bimanual, multi-joint upper-limb movements with eight degrees of freedom: 64.0% (SD 5.1) success with a virtual avatar at home, 70.9% (SD 11.6) with the exoskeleton in the laboratory [2]
Decoder stabilityDecoding models reusable for up to about 7 weeks without recalibration [2]
Recorder stabilityA 2021 follow-up characterized the long-term stability of the chronic WIMAGINE epidural recorders in tetraplegic patients [3]

Primary sources

  1. ClinicalTrials.gov, NCT02550522. Verified October 28, 2026.
  2. Benabid et al., An exoskeleton controlled by an epidural wireless brain-machine interface in a tetraplegic patient: a proof-of-concept demonstration, Lancet Neurology 2019;18(12):1112-1122. Peer reviewed.
  3. Larzabal et al., Long-term stability of the chronic epidural wireless recorder WIMAGINE in tetraplegic patients, Journal of Neural Engineering 2021;18(5). Peer reviewed.